A novel Cas9 fusion protein promotes targeted genome editing with reduced mutational burden in primary human cells.
Carusillo A, Haider S, Schafer R, Rhiel M, Turk D, Chmielewski KO, Klermund J, Mosti L, Andrieux G, Schafer R, Cornu TI, Cathomen T, Mussolino C
Nucleic Acids Res. 2023 May 22;51(9):4660-4673. doi: 10.1093/nar/gkad255. PubMed Article
Carusillo A, Haider S, Schafer R, Rhiel M, Turk D, Chmielewski KO, Klermund J, Mosti L, Andrieux G, Schafer R, Cornu TI, Cathomen T, Mussolino C
Nucleic Acids Res. 2023 May 22;51(9):4660-4673. doi: 10.1093/nar/gkad255. PubMed Article
Plasmids from Article
| ID | Plasmid | Purpose |
|---|---|---|
| 200254 | 2333_Cas9-CtIP-dnRNF168 | This plasmid expresses the Cas9-CtIP-dnRNF168 in mammalian cells |